HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania

[1] de Villiers EM(2004)Classification of papillomaviruses Virology 324 17-27

[2] Fauquet C(1999)Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12-19

[3] Broker TR(2003)Epidemiologic classification of Human Papilloma Virus types associated with cervical cancer N Engl J Med 348 518-527

[4] Bernard HU(2006)The epidemiology of human papillomavirus infection and its association with cervical cancer Int J Gynaecol Obstet 94 (Supplement 1):S8-S21

[5] zur Hausen H(2011)The importance of monitoring protocols in cervical carcinoma screening Rom J Morphol Embryol 52 297-302

[6] Walboomers JM(2001)Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis Lancet Infect Dis 7 453-459

[7] Jacobs MV(2009)European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1 Cytopathology 20 5-16

[8] Manos MM(2008)Evaluation of different techniques for identification of human papillomavirus types of low prevalence J Clin Microbiol 46 1606-13

[9] Muňoz N(2010)WHO Human Papillomavirus Laboratory Network., Global proficiency study of human papillomavirus genotyping J Clin Microbiol 48 4147-55

[10] Bosch X(2009)Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union Eur J Cancer 45 2685-708

[1] de Villiers EM(2004)Classification of papillomaviruses Virology 324 17-27

[2] Fauquet C(1999)Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12-19

[3] Broker TR(2003)Epidemiologic classification of Human Papilloma Virus types associated with cervical cancer N Engl J Med 348 518-527

[4] Bernard HU(2006)The epidemiology of human papillomavirus infection and its association with cervical cancer Int J Gynaecol Obstet 94 (Supplement 1):S8-S21

[5] zur Hausen H(2011)The importance of monitoring protocols in cervical carcinoma screening Rom J Morphol Embryol 52 297-302

[6] Walboomers JM(2001)Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis Lancet Infect Dis 7 453-459

[7] Jacobs MV(2009)European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1 Cytopathology 20 5-16

[8] Manos MM(2008)Evaluation of different techniques for identification of human papillomavirus types of low prevalence J Clin Microbiol 46 1606-13

[9] Muňoz N(2010)WHO Human Papillomavirus Laboratory Network., Global proficiency study of human papillomavirus genotyping J Clin Microbiol 48 4147-55

[10] Bosch X(2009)Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union Eur J Cancer 45 2685-708